Podcast about genetic testing for inherited retinal disease and how getting a genetic diagnosis empowers the IRD community. The guests are Kari Branham (genetic counsellor) and Ben Shaberman (Foundation Fighting Blindness).
We are pleased to welcome Naveed Shams, MD, PhD to our management team as Chief Scientific Officer. He will be leading research as well as the early clinical development of ProQR's investigational RNA therapies for inherited retinal diseases.
He is one of the founders of ProQR, but even long before that Gerard Platenburg was involved in the development of RNA therapies. Even so, after decades of working on them he still gets enthusiastic when talking about RNA.
During a ProQR Expert Perspective call Dr. Girach (CMO at ProQR) discusses findings from an open label extension study of sepofarsen for LCA10 with Retinal Disease expert Dr. MacDonald (Prof Emer University of Alberta).
The work at ProQR would not be possible without the help from patient organizations and foundations. One of the main supporters is the Foundation Fighting Blindness, who generously provided funding for the clinical development of QR-421a.
Interview with Dr. Ted Dryja, Scientific Advisory Board member. The pioneer in inherited retinal diseases joined ProQR to help push the organization forward. “I'm excited about what RNA technology may do for ProQR’s ophthalmology pipeline."